QC Healthcare integrates AI-driven blood monitoring into telehealth

The integration begins with My Pediatric Doctor and My Adult Doctor, platforms that offer 24/7 care across the United States. Sanguina’s technology uses video analysis to track hemoglobin levels and peripheral perfusion—a metric known as the Circulation Score—which quantifies blood return speed in the fingertips. By digitizing these assessments, the companies intend to bridge the gap between infrequent laboratory blood draws, offering clinicians objective data trends to inform remote decision-making.

QC Healthcare CEO Eric Doherty noted that the move reflects a shift toward proactive, technology-enabled prevention. Future plans include extending these capabilities to specialized platforms currently in development, specifically My VA Doctor and My Oncology Doctor. The companies also intend to pursue international deployments, targeting regions where access to traditional laboratory facilities remains a significant hurdle for patients. While the technology provides actionable context for telehealth visits, both firms emphasize that these screenings are intended to support clinical workflows rather than replace standard lab testing or physical examinations.